Reference | No. of procedures | Open | Percutaneous | Precaution taken | # of Infected (HCWs) | Following up (HCWs) |
Omar et al., 2020 [17] . | 100 | 25 | 75 | Only full PPE*, in regular rooms | 8 members All Non infected | Not specified |
Yokokawa T et al., 2021 [18] . | 35 | 35 | 0 | All used PPE, 164 used N95 + eye protection, 25 used PAPR, 16 in NPR, 19 in regular rooms | 184 members All Non infected | Not specified |
Chao TN et al., 2020 [19] . | 53 | 24 | 29 | All used PPE, 26 used N95 + eye protection, 30 used PAPR All in regular rooms expect 1 in NPR | 11 members All Non infected | By symptoms |
Weiss KD et al., 2020 [20] . | 28 | 1 | 27 | Procedures performed under controlled apneic conditions, all used full PPE* | 9 members All Non infected | By symptoms |
Volo T et al., 2020 [21] . | 23 | 22 | 1 | All used full PPE*, all done in NPR | 6 members All Non infected | By nasopharyngeal swabs |
Angel L et al., 2020 [22] . | 104 | 6 | 98 | All used full PPE*, 96 in NPR | 8 members All Non infected | By nasopharyngeal swabs and symptoms |
Sun BJ et al., 2020 [23] . | 12 | 0 | 12 | All used full PPE*, 1 used PAPR, all procedures in NPR | 4 members All Non infected | Not specified |
Picetti E et al., 2020 [24] . | 66 | 66 | 0 | All used full PPE*, in regular room | 6 members All Non infected | By nasopharyngeal swabs, serology and symptoms |
Takhar A et al., 2020 [25] . | 81 | 5 | 76 | All used full PEE*, all used PAPR or FFP3, not mentioned if any done in NPR | 71 members All Non infected | By symptoms |